NCT01323062 2018-12-04
Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Subjects
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed
Clinical Trials
6 trialsNCT01999673 2017-04-21
SUNRISE
Peregrine Pharmaceuticals
Phase 3 Completed
NCT01138163 2017-04-19
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Peregrine Pharmaceuticals
Phase 2 Completed
NCT01160601 2017-04-19
Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer
Peregrine Pharmaceuticals
Phase 2 Completed
NCT02673814 2016-08-01
Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung Cancer
Peregrine Pharmaceuticals
Phase 2 Withdrawn
NCT00687817 2011-03-24
Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer
Peregrine Pharmaceuticals
Phase 2 Completed